81 related articles for article (PubMed ID: 7600545)
21. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice.
Russell WE; Kaufmann WK; Sitaric S; Luetteke NC; Lee DC
Mol Carcinog; 1996 Mar; 15(3):183-9. PubMed ID: 8597531
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of Ginkgo biloba against rat liver carcinogenesis.
Dias MC; Rodrigues MA; Reimberg MC; Barbisan LF
Chem Biol Interact; 2008 May; 173(1):32-42. PubMed ID: 18367157
[TBL] [Abstract][Full Text] [Related]
23. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice.
Takagi H; Sharp R; Takayama H; Anver MR; Ward JM; Merlino G
Cancer Res; 1993 Sep; 53(18):4329-36. PubMed ID: 8364928
[TBL] [Abstract][Full Text] [Related]
24. Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis.
Huang X; Yu C; Jin C; Kobayashi M; Bowles CA; Wang F; McKeehan WL
Cancer Res; 2006 Feb; 66(3):1481-90. PubMed ID: 16452204
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
[TBL] [Abstract][Full Text] [Related]
26. Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development.
Qiu LW; Yao DF; Zong L; Lu YY; Huang H; Wu W; Wu XH
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):406-11. PubMed ID: 18693177
[TBL] [Abstract][Full Text] [Related]
27. Altered expression of transforming growth factor-alpha: an early event in renal cell carcinoma development.
Everitt JI; Walker CL; Goldsworthy TW; Wolf DC
Mol Carcinog; 1997 Jul; 19(3):213-9. PubMed ID: 9254888
[TBL] [Abstract][Full Text] [Related]
28. Target cell populations in virus-associated hepatocarcinogenesis.
Thorgeirsson SS
Princess Takamatsu Symp; 1995; 25():163-70. PubMed ID: 8875621
[TBL] [Abstract][Full Text] [Related]
29. Association between expression of transforming growth factor-alpha and progression of hepatocellular foci to neoplasms.
Kaufmann WK; Zhang Y; Kaufman DG
Carcinogenesis; 1992 Aug; 13(8):1481-3. PubMed ID: 1499100
[TBL] [Abstract][Full Text] [Related]
30. Models of hepatocarcinogenesis in the rat--contrasts and comparisons.
Goldsworthy TL; Hanigan MH; Pitot HC
Crit Rev Toxicol; 1986; 17(1):61-89. PubMed ID: 3527567
[TBL] [Abstract][Full Text] [Related]
31. Experimental induction of hepatocellular carcinoma as a paradigm for carcinogenesis.
Farber E
Clin Physiol Biochem; 1987; 5(3-4):152-9. PubMed ID: 3621796
[TBL] [Abstract][Full Text] [Related]
32. Stage-specific gene expression during hepatocarcinogenesis in the rat.
Pitot HC
J Cancer Res Clin Oncol; 1996; 122(5):257-65. PubMed ID: 8609148
[TBL] [Abstract][Full Text] [Related]
33. Adventures in hepatocarcinogenesis.
Pitot HC
Annu Rev Pathol; 2007; 2():1-29. PubMed ID: 18039091
[TBL] [Abstract][Full Text] [Related]
34. Environmental modifiers in carcinogenesis.
Pitot HC
IARC Sci Publ; 1982; (39):165-76. PubMed ID: 6295932
[TBL] [Abstract][Full Text] [Related]
35. Short-term fasting and the reversal of the stage of promotion in rat hepatocarcinogenesis: role of cell replication, apoptosis, and gene expression.
Hikita H; Vaughan J; Babcock K; Pitot HC
Toxicol Sci; 1999 Dec; 52(2 Suppl):17-23. PubMed ID: 10630586
[TBL] [Abstract][Full Text] [Related]
36. Quantitative comparison of initiation and mutation phenotypes in hepatocytes of the analbuminemic rat.
Dragan YP; Laufer C; Koleske AJ; Drinkwater N; Pitot HC
Jpn J Cancer Res; 1993 Feb; 84(2):175-83. PubMed ID: 8463134
[TBL] [Abstract][Full Text] [Related]
37. [Immunomorphological analysis of the level of differentiation of hepatocellular tumors in rats].
Gel'shteĭn VI; Chipysheva TA; Bannikov GA
Arkh Patol; 1984; 46(9):75-81. PubMed ID: 6210073
[TBL] [Abstract][Full Text] [Related]
38. [Distribution of antigneic markers of differentiation--ligandin and alpha-fetoprotein--in the early stages of chemical carcinogenesis in rat liver].
Bannikov GA; Gel'shteĭn VI; Chipysheva TA
Vestn Akad Med Nauk SSSR; 1977; (3):39-41. PubMed ID: 70124
[No Abstract] [Full Text] [Related]
39. Neoplastic progression in experimental hepatocarcinogenesis.
Scherer E
Biochim Biophys Acta; 1984; 738(4):219-36. PubMed ID: 6394049
[TBL] [Abstract][Full Text] [Related]
40. Review article: the stages of gastrointestinal carcinogenesis--application of rodent models to human disease.
Pitot HC; Hikita H; Dragan Y; Sargent L; Haas M
Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():153-60. PubMed ID: 10807417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
